Application of composition containing edaravone and dexborneol in improving or treating cognitive impairment
AssigneesNeurodawn Pharmaceutical Co., Ltd., Simcere Pharmaceutical Co., Ltd.
InventorsZhengping ZHANG, Lei WANG, Rong CHEN, Shibao YANG, Jinsheng REN
Life of this patent
Estimating the term…
Abstract
An application of a composition in improving or treating cognitive impairment. The composition contains 3-methyl-1-phenyl-2-pyrazolin-5-one or a pharmaceutically acceptable salt thereof and borneol or dexborneol. The cognitive impairment comprises Alzheimer's disease (AD), vascular dementia (VD), mild cognitive impairment (MCI), and other types of dementia.
Claims10
A method for improving or treating cognitive impairment, comprising administering to a patient in need a composition, wherein the composition contains 3-methyl-1-phenyl-2-pyrazolin-5-one or a pharmaceutically acceptable salt thereof and dexborneol.
(canceled)
Dependencies are inferred from the claim text.